nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute myeloid leukemia and myelodysplastic syndrome following breast cancer: Increased frequency of other cancers and of cancers in multiple family members
|
Padmanabhan, Aruna |
|
2008 |
32 |
12 |
p. 1820-1823 4 p. |
artikel |
2 |
Acute promyelocytic leukemia with amplification of PML-RARα rearrangement: Clinical implications
|
Luatti, Simona |
|
2008 |
32 |
12 |
p. 1941-1943 3 p. |
artikel |
3 |
AIDS-related Burkitt lymphoma—A heterogeneous disease?
|
Danilov, Alexey V. |
|
2008 |
32 |
12 |
p. 1939-1941 3 p. |
artikel |
4 |
Allogeneic bone marrow transplantation after l-asparaginase-induced pancreatitis in a patient with acute lymphoblastic leukemia
|
Yamada, Yasuhiro |
|
2008 |
32 |
12 |
p. 1944-1946 3 p. |
artikel |
5 |
An evaluation of the cardiotoxicity of imatinib mesylate
|
Ribeiro, Antonio Luiz |
|
2008 |
32 |
12 |
p. 1809-1814 6 p. |
artikel |
6 |
A Pilot study of allogeneic cellular therapy for patients with advanced hematologic malignancies
|
Medina, Daniel J. |
|
2008 |
32 |
12 |
p. 1842-1848 7 p. |
artikel |
7 |
Aplastic anaemia preceding acute lymphoblastic leukaemia in an adult with isolated deletion of chromosome 9q
|
Kelly, Kevin |
|
2008 |
32 |
12 |
p. 1936-1938 3 p. |
artikel |
8 |
Apoptotic effects on B-cell chronic lymphocytic leukemia (B-CLL) cells of heterocyclic compounds isolated from Guttiferaes
|
Menasria, F. |
|
2008 |
32 |
12 |
p. 1914-1926 13 p. |
artikel |
9 |
Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm
|
Fend, Falko |
|
2008 |
32 |
12 |
p. 1931-1935 5 p. |
artikel |
10 |
Bone marrow cell cycle markers in inherited bone marrow failure syndromes
|
Al-Rahawan, Mohamad M. |
|
2008 |
32 |
12 |
p. 1793-1799 7 p. |
artikel |
11 |
CDDO-imidazolide mediated inhibition of malignant cell growth in Waldenström macroglobulinemia
|
Elsawa, Sherine F. |
|
2008 |
32 |
12 |
p. 1895-1902 8 p. |
artikel |
12 |
Clinicopathologic features and treatment outcome of primary breast diffuse large B-cell lymphoma
|
Niitsu, Nozomi |
|
2008 |
32 |
12 |
p. 1837-1841 5 p. |
artikel |
13 |
Completely mismatched allogeneic CD3/CD28 cross-linked Th1 memory cells elicit anti-leukemia effects in unconditioned hosts without GVHD toxicity
|
Har-Noy, M. |
|
2008 |
32 |
12 |
p. 1903-1913 11 p. |
artikel |
14 |
Cytogenetic abnormalities in Tunisian de novo myelodysplastic syndrome: A comparison with other populations
|
Gmidène, Abir |
|
2008 |
32 |
12 |
p. 1824-1829 6 p. |
artikel |
15 |
Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early–intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab
|
Zent, Clive S. |
|
2008 |
32 |
12 |
p. 1849-1856 8 p. |
artikel |
16 |
Editorial board and publication information
|
|
|
2008 |
32 |
12 |
p. CO2- 1 p. |
artikel |
17 |
Erratum to “Multiple myeloma cells directly stimulate bone resorption in vitro by down-regulating mature osteoclast apoptosis” [Leukemia Research 32 (2008) 1279–1287]
|
El Hajj Dib, Iman |
|
2008 |
32 |
12 |
p. 1947- 1 p. |
artikel |
18 |
Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years
|
Candoni, Anna |
|
2008 |
32 |
12 |
p. 1800-1808 9 p. |
artikel |
19 |
Involvement of the TGF-β and mTOR/p70S6Kinase pathways in the transformation process induced by v-ErbA
|
Gonin-Giraud, S. |
|
2008 |
32 |
12 |
p. 1878-1888 11 p. |
artikel |
20 |
Nuclear organization of PML bodies in leukaemic and multiple myeloma cells
|
Krejčí, Jana |
|
2008 |
32 |
12 |
p. 1866-1877 12 p. |
artikel |
21 |
PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases
|
Gontarewicz, Artur |
|
2008 |
32 |
12 |
p. 1857-1865 9 p. |
artikel |
22 |
Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML
|
Walker, Alison R. |
|
2008 |
32 |
12 |
p. 1830-1836 7 p. |
artikel |
23 |
Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): Clinicopathologic comparison of del(5q)-positive and -negative cases
|
Santana-Davila, Rafael |
|
2008 |
32 |
12 |
p. 1927-1930 4 p. |
artikel |
24 |
Semenogelin I expression in myeloma cells can be upregulated pharmacologically
|
Zhang, Yana |
|
2008 |
32 |
12 |
p. 1889-1894 6 p. |
artikel |
25 |
The significance of soluble HLA-G plasma levels as well as messenger HLA-G for B-cell chronic lymphocytic leukemia (B-CLL)
|
Giannopoulos, K. |
|
2008 |
32 |
12 |
p. 1815-1819 5 p. |
artikel |